Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Objective
Type I interferon (IFN) signaling is a central pathogenic pathway in systemic lupus erythematosus (SLE), and therapeutics targeting type I IFN signaling are in development. Multiple proteins with overlapping functions play a role in IFN signaling, but the signaling events downstream of receptor engagement are unclear. This study was undertaken to investigate the roles of the type I and type II IFN signaling components IFN‐α/β/ω receptor 2 (IFNAR‐2), IFN regulatory factor 9 (IRF‐9), and STAT‐1 in a mouse model of SLE.
Methods
We used immunohistochemical staining and highly multiplexed assays to characterize pathologic changes in histology, autoantibody production, cytokine/chemokine profiles, and STAT phosphorylation in order to investigate the individual roles of IFNAR‐2, IRF‐9, and STAT‐1 in MRL/lpr mice.
Results
We found that STAT‐1−/− mice, but not IRF‐9−/− or IFNAR‐2−/− mice, developed interstitial nephritis characterized by infiltration with retinoic acid receptor–related orphan nuclear receptor γt–positive lymphocytes, macrophages, and eosinophils. Despite pronounced interstitial kidney disease and abnormal kidney function, STAT‐1−/− mice had decreased proteinuria, glomerulonephritis, and autoantibody production. Phosphospecific flow cytometry revealed shunting of STAT phosphorylation from STAT‐1 to STAT‐3/4.
Conclusion
We describe unique contributions of STAT‐1 to pathology in different kidney compartments in a mouse model, and provide potentially novel insight into tubulointerstitial nephritis, a poorly understood complication that predicts end‐stage kidney disease in SLE patients.